locketpvc0
About
CONKO-006: The randomised double-blinded stage IIb-study involving additive therapy along with gemcitabine + sorafenib/placebo inside people with R1 resection associated with pancreatic cancers - Final results.
CONKO-006: The randomised double-blinded stage IIb-study involving additive therapy along with gemcitabine + sorafenib/placebo inside people with R1 resection associated with pancreatic cancers - Final results.